Migraines with Aura and Stroke Risk in Women: What Every Migraine Patient Needs to Know

Women with migraine with aura face a 2.7-fold increased risk of ischemic stroke compared to women without migraine. When combined with estrogen-containing contraceptives, this risk rises to 6.1-fold. Despite clear contraindications in ACOG and CDC guidelines, a 2025 Boston University study found that 15% of reproductive-aged women diagnosed with migraine with aura still received prescriptions for estrogen-containing contraceptives. The mechanism involves cortical spreading depression, endothelial dysfunction, and platelet hyperactivity creating a prothrombotic state that estrogen amplifies.

She had migraines with aura since age 16. She had been on combined oral contraceptives for 11 years. Her gynecologist had not mentioned the word stroke.

I met her at 34. She came to my cardiology clinic not for her migraines but for palpitations. During the history, I asked about her contraception. She mentioned the pill. I asked about her migraines. She described the visual symptoms: shimmering zigzag lines that expanded across her left visual field over 20 minutes, followed by a throbbing right-sided headache. Classic migraine with aura.

I asked who had prescribed her birth control. Her gynecologist. I asked if anyone had discussed stroke risk. No one had. Not in 11 years.

This is not an isolated failure. This is a systems failure. And it is happening to thousands of women right now.

The Numbers That Should Have Changed Her Prescription

The data on migraine with aura and stroke risk are not new. They are not controversial. They are settled science that somehow has not reached the exam room.

The 2023 CDC analysis published in Contraception examined stroke risk across migraine subtypes and contraceptive use Batur 2023. The findings were unambiguous. Women with migraine with aura who do not use combined hormonal contraceptives have an odds ratio of 2.7 for ischemic stroke compared to women with neither exposure. 5 / Solid

Women with migraine with aura who use combined hormonal contraceptives have an odds ratio of 6.1 for ischemic stroke. 5 / Solid

These numbers demand attention. The 2.7-fold baseline risk from migraine with aura alone is already clinically significant. Adding estrogen-containing contraception more than doubles it again.

The absolute risk matters too. In women aged 20 to 44, the background rate of ischemic stroke is approximately 3 to 4 per 100,000 person-years. With migraine with aura, this rises to 7 to 9 per 100,000 person-years MacClellan 2007. With the addition of combined hormonal contraceptives, estimates approach 18 to 24 per 100,000 person-years.

Young women assume stroke is an old person’s disease. It is not. Ischemic stroke in women under 45 is rising. And migraine with aura plus estrogen exposure is a preventable contributor.

The 2025 Boston University study delivered the damning follow-up. Despite 15 years of guideline contraindications, approximately 15% of reproductive-aged women diagnosed with migraine with aura still receive prescriptions for estrogen-containing contraceptives. The guidelines exist. The prescriptions continue.

The Biology of the Aura: Why It Marks Vascular Vulnerability

Migraine with aura is not simply migraine plus a visual show. The aura signals a distinct pathophysiology. And that pathophysiology explains the stroke connection.

The aura originates from cortical spreading depression. This is a wave of neuronal depolarization that moves across the cortex at 2 to 3 millimeters per minute. As it passes, neurons fire intensely, then fall silent. The visual symptoms, the zigzag lines and scotomas, map directly onto this wave moving through the visual cortex.

But cortical spreading depression does not stay confined to neurons. It triggers a cascade of vascular events Tietjen 2009.

First, transient oligemia. Blood flow to the affected cortical region drops by 20 to 30% and remains reduced for up to an hour. This is not ischemia in the stroke sense, but it reflects abnormal vascular reactivity.

Second, endothelial dysfunction. Women with migraine with aura show reduced flow-mediated dilation in the brachial artery, a measure of systemic endothelial health. The endothelium, which normally releases nitric oxide to prevent clotting and maintain vascular tone, is impaired.

Third, platelet hyperactivity. Studies document elevated P-selectin and von Willebrand factor in women with migraine with aura. Platelets are primed to aggregate. The clotting cascade sits closer to activation.

This triad, oligemia, endothelial dysfunction, and platelet hyperactivity, creates what researchers call a prothrombotic state. The blood is ready to clot. The vessels are ready to spasm. The conditions for stroke exist.

Women don’t die from what they have. Women die from what they hold. And many women hold a migraine diagnosis that has never been connected to its vascular implications.

Why Estrogen Makes Everything Worse

Estrogen is not inherently dangerous. Endogenous estrogen provides cardiovascular protection for most of a woman’s reproductive years. But exogenous estrogen, delivered in pharmacologic doses through combined hormonal contraceptives, interacts with the migraine-with-aura biology in dangerous ways.

Combined oral contraceptives increase thrombin generation. They raise fibrinogen levels. They increase plasminogen activator inhibitor-1, which suppresses the body’s natural clot-dissolving mechanisms. They shift the hemostatic balance toward clot formation MacGregor 2016. 5 / Solid

In a woman with normal vascular function, these effects are generally manageable. The absolute risk of venous thromboembolism from combined oral contraceptives is real but low. The risk-benefit calculation favors contraception for most women.

But in a woman with migraine with aura, the prothrombotic effects of estrogen land on already-compromised vascular terrain. The endothelium is already dysfunctional. The platelets are already hyperactive. Adding estrogen pours accelerant on kindling.

The 2024 European Headache Federation and European Society of Contraception consensus statement addressed this directly Sacco 2024. Combined hormonal contraceptives are classified as category 4 (absolutely contraindicated) for women with migraine with aura. Not category 3 (risks usually outweigh benefits). Category 4. Do not prescribe.

ACOG’s Practice Bulletin 206 states the same ACOG 2019. The CDC’s Medical Eligibility Criteria for Contraceptive Use agrees. Three major guideline bodies. One consistent message. Yet the prescriptions continue.

The Compounding Risk of Smoking

If estrogen pours accelerant on kindling, smoking strikes the match.

The interaction between migraine with aura, combined hormonal contraceptives, and smoking is not additive. It is multiplicative. Among women with migraine with aura who smoke, the odds ratio for ischemic stroke reaches 9.0 compared to non-smoking women without migraine Kurth 2009. 5 / Solid

Nine times the risk. This is not a subtle elevation. This is a preventable catastrophe.

Smoking damages the endothelium through oxidative stress. It increases platelet aggregation. It promotes atherosclerosis. Every mechanism that migraine with aura activates, smoking amplifies.

When I see a young woman with migraine with aura, my first questions after confirming the diagnosis are about contraception and smoking. If she is on combined hormonal contraceptives, we discuss switching that day. If she smokes, we discuss cessation that day. These are not elective conversations. These are urgent interventions.

The tragedy is that many women with migraine with aura who smoke and take combined oral contraceptives have no idea they are carrying this risk. Their neurologist manages the migraines. Their gynecologist manages the contraception. No one connects the dots.

What Your Migraine Diary Is Really Telling You

The clinical framework I use with migraine patients is The Vascular Warning Signal Model. Migraine with aura is not just a headache disorder. It is a marker of underlying vascular susceptibility that has implications beyond the skull.

Your migraine diary reveals more than trigger patterns. It reveals vascular behavior.

If your auras are increasing in frequency, this may reflect worsening endothelial function. If your migraines are becoming resistant to treatments that previously worked, this may signal vascular changes. If you develop new aura symptoms after age 40, this demands immediate evaluation to rule out other causes.

The Lancet Neurology review on sex differences in migraine epidemiology documented that women experience migraines at three times the rate of men, with the highest prevalence during reproductive years Vetvik 2017. This is not coincidental. Estrogen fluctuations modulate migraine frequency. But they also modulate vascular risk.

Perimenopause brings particular complexity. Estrogen levels become erratic. Migraine patterns often worsen. And this is precisely the time when cardiovascular risk begins its steep climb. Women in perimenopause with migraine with aura need coordinated care between neurology, gynecology, and cardiology.

The cardiovascular surveillance I recommend for women with frequent migraines with aura includes baseline assessment of traditional risk factors: blood pressure, lipid panel, fasting glucose. But I also recommend ApoB, Lp(a), and hs-CRP to characterize vascular risk more precisely. These tests reveal information that a standard lipid panel misses.

Safe Contraceptive Alternatives

The message is not that women with migraine with aura cannot use effective contraception. The message is that they cannot use estrogen-containing contraception.

Progestin-only pills carry no increased stroke risk in women with migraine with aura. The hormonal IUD, which delivers levonorgestrel locally with minimal systemic absorption, is safe and highly effective. The copper IUD contains no hormones at all. The contraceptive implant uses progestin only.

The 2024 European consensus statement provides clear guidance. For women with migraine with aura, progestin-only methods are classified as category 1 (no restriction) or category 2 (benefits generally outweigh risks, depending on the specific method and patient factors).

The conversation should happen at the first prescription. Any woman presenting for contraception should be asked about migraine history. Does she have migraines? Do they include aura? The answer determines which methods are safe.

For women currently on combined hormonal contraceptives who discover they should not be, the transition is straightforward. Most progestin-only methods can be started immediately. There is no need for a washout period. The stroke risk from estrogen decreases once the estrogen is discontinued.

The Conversation That Needs to Happen

Here is what the appointment should sound like.

Prescriber: “Before we discuss contraception, I need to ask about migraines. Do you get migraines?”

Patient: “Yes, since I was a teenager.”

Prescriber: “Do you ever have warning symptoms before the headache starts? Visual disturbances like flashing lights, zigzag lines, or blind spots? Numbness or tingling? Difficulty speaking?”

Patient: “Yes, I see shimmering lines that spread across my vision.”

Prescriber: “That’s called migraine with aura. It’s important because it changes which birth control methods are safe for you. Combined pills, the patch, and the ring all contain estrogen, which significantly increases stroke risk in women with migraine with aura. I’m going to recommend a progestin-only method instead. The hormonal IUD is excellent, highly effective, and has no stroke risk. Can we discuss that option?”

This conversation takes two minutes. It prevents strokes.

For the 15% of women with migraine with aura who are currently on estrogen-containing contraceptives, the conversation is different.

“I see you’re on [brand name] birth control. I also see from your history that you have migraines with aura. This combination carries a significantly increased stroke risk. We need to switch you to a different method. Let’s do that today.”

No equivocation. No “something to think about.” Today.

When to Worry: Red Flags in Migraine Patients

Most strokes in young women with migraine with aura are preventable through contraceptive choice. But some require acute recognition.

If a woman with migraine with aura experiences an aura that lasts longer than 60 minutes, this is not typical. Prolonged aura may represent a transient ischemic attack or migrating stroke.

If a woman with migraine with aura develops sudden weakness on one side of her body, speech difficulty, or severe headache unlike her usual migraines, this is not a migraine. This is a stroke until proven otherwise. Call 911.

If a woman with migraine with aura develops new aura symptoms after age 40 without a clear explanation, this warrants imaging. New-onset aura in midlife can indicate other vascular pathology.

The teaching point is simple. Women with migraine with aura are at higher baseline stroke risk. They need to recognize stroke symptoms. They need to act immediately if those symptoms appear. And their families need to know too.

The Prescription She Should Have Received

My patient, the one who started this article, switched to a hormonal IUD that week. She also learned that her 14-year-old daughter, who had just started having migraines with visual symptoms, should never be started on estrogen-containing contraception.

The information transferred in one generation. But only because someone finally asked the right questions.

I cannot undo 11 years of unnecessary risk for my patient. But I can ensure that every woman with migraine with aura who walks into my clinic leaves knowing three things: she has a vascular risk marker, estrogen-containing contraception is contraindicated, and safe alternatives exist.

The guidelines are clear. The evidence is solid. The implementation gap is the problem. And closing that gap is not complicated. It requires one question at every contraceptive visit: “Do you have migraines with aura?”

At your next appointment, whether with your gynecologist, primary care physician, or neurologist, bring this information. If you have migraines with aura and are currently taking combined hormonal contraceptives, say these words: “I have migraine with aura. I understand this is a contraindication to estrogen-containing contraception. I would like to discuss switching to a progestin-only method today.”

If you smoke, add this: “I also want to discuss smoking cessation resources today.”

These two interventions, eliminating estrogen exposure and eliminating smoking, can reduce your stroke risk from 9 times baseline to near baseline. No medication required. No procedure. Just the right information, acted upon.

Frequently Asked Questions

Can I take birth control pills if I have migraines with aura?

Combined hormonal contraceptives containing estrogen are absolutely contraindicated in women with migraine with aura. This is a category 4 classification in CDC, ACOG, and European guidelines, meaning the risks are unacceptable and the method should not be used. The 2023 CDC analysis documented an odds ratio of 6.1 for ischemic stroke in women with migraine with aura who use combined hormonal contraceptives compared to women with neither exposure. Progestin-only methods are safe alternatives. The hormonal IUD delivers levonorgestrel locally with minimal systemic absorption and carries no increased stroke risk. Progestin-only pills, the contraceptive implant, and the copper IUD are also safe options. Do not continue estrogen-containing contraception if you have migraine with aura.

What is the difference between migraine with aura and migraine without aura for stroke risk?

The distinction is clinically critical. Migraine with aura carries an odds ratio of 2.7 for ischemic stroke compared to women without migraine. Migraine without aura shows minimal to no increased stroke risk in most studies. The difference lies in the underlying pathophysiology. The aura reflects cortical spreading depression, a wave of neuronal depolarization that triggers vascular dysfunction, endothelial impairment, and platelet hyperactivity. These mechanisms create a prothrombotic state that does not occur in migraine without aura. When your physician asks about your migraines, be specific about whether you experience warning symptoms before the headache: visual disturbances, numbness, tingling, or speech difficulty. This information determines your vascular risk profile and your contraceptive options.

How do I know if my migraines have aura?

Aura symptoms typically develop gradually over 5 to 60 minutes and precede the headache phase. Visual aura is most common: you may see zigzag lines, shimmering or flashing lights, blind spots, or tunnel vision. Some women experience sensory aura with numbness or tingling that spreads from the hand up the arm or across the face. Speech difficulty or word-finding problems can occur. The key feature is gradual development. Stroke symptoms appear suddenly, while aura symptoms build over minutes. Keep a migraine diary that documents not just headache severity but any warning symptoms. Note the sequence: what symptom appeared first, how long each lasted, whether the headache followed. Bring this diary to your neurologist appointment. The pattern will confirm whether you have migraine with aura.

Should I stop my birth control pills if I have migraines with aura?

Yes, but do it correctly. Do not stop your contraception without a replacement method in place unless you are prepared for pregnancy. Contact your prescriber immediately, ideally today, to discuss transitioning to a progestin-only method. Most transitions can happen same-day or within one week. Your provider may start you on a progestin-only pill immediately while scheduling IUD insertion. The stroke risk associated with estrogen begins to decrease once you discontinue the estrogen-containing contraceptive. You do not need a washout period before starting progestin-only methods. The urgency is real: every cycle on estrogen-containing contraception carries elevated stroke risk. But the solution is accessible. You can switch methods without a gap in pregnancy protection.

Does smoking make migraine-related stroke risk worse?

Dramatically and multiplicatively. Women with migraine with aura who smoke have an odds ratio of 9.0 for ischemic stroke compared to non-smoking women without migraine. Smoking damages the endothelium through oxidative stress, increases platelet aggregation, and promotes atherosclerosis. These effects compound the vascular dysfunction already present in migraine with aura. If you have migraine with aura and you smoke, cessation is the single most impactful intervention for reducing your stroke risk. More impactful than any medication. More impactful than any procedure. Ask your physician about evidence-based cessation methods: nicotine replacement therapy, varenicline, or bupropion all improve quit rates. Combine pharmacotherapy with behavioral support for the highest success probability. Your vascular future depends on this decision.